169 related articles for article (PubMed ID: 34024409)
1. Care Delivery Models and Interstitial Lung Disease: The Role of the Specialized Center.
Fisher JH; Cottin V
Clin Chest Med; 2021 Jun; 42(2):347-355. PubMed ID: 34024409
[TBL] [Abstract][Full Text] [Related]
2. Implementing an interstitial lung disease clinic improves survival without increasing health care resource utilization.
Povitz M; Li L; Hosein K; Shariff S; Mura M
Pulm Pharmacol Ther; 2019 Jun; 56():94-99. PubMed ID: 30930173
[TBL] [Abstract][Full Text] [Related]
3. Provider Perspectives on and Access to Palliative Care for Patients With Interstitial Lung Disease.
Gersten RA; Seth B; Arellano L; Shore J; O'Hare L; Patel N; Safdar Z; Krishna R; Mageto Y; Cochran D; Lindell K; Danoff SK;
Chest; 2022 Aug; 162(2):375-384. PubMed ID: 35305969
[TBL] [Abstract][Full Text] [Related]
4. Essential Components of an Interstitial Lung Disease Clinic: Results From a Delphi Survey and Patient Focus Group Analysis.
Graney BA; He C; Marll M; Matson S; Bianchi P; Cosgrove GP; Lee JS;
Chest; 2021 Apr; 159(4):1517-1530. PubMed ID: 33031832
[TBL] [Abstract][Full Text] [Related]
5. Clinical impact of the interstitial lung disease multidisciplinary service.
Jo HE; Glaspole IN; Levin KC; McCormack SR; Mahar AM; Cooper WA; Cameron R; Ellis SJ; Cottee AM; Webster SE; Troy LK; Torzillo PJ; Corte P; Symons KM; Taylor N; Corte TJ
Respirology; 2016 Nov; 21(8):1438-1444. PubMed ID: 27427515
[TBL] [Abstract][Full Text] [Related]
6. [Survey of Specialist Pulmonary Medicine Health Care Structures for Patients with Interstitial Lung Disease in Nordrhein-Westfalen, Germany - A Pilot Project of the Western German Respiratory Society (WdGP)].
Hagmeyer L; Haidl P; Westhoff M; Schulte W; Randerath W; Lorenz J
Pneumologie; 2018 Jul; 72(7):523-530. PubMed ID: 29788515
[TBL] [Abstract][Full Text] [Related]
7. Role of a Regional Multidisciplinary Conference in the Diagnosis of Interstitial Lung Disease.
Grewal JS; Morisset J; Fisher JH; Churg AM; Bilawich AM; Ellis J; English JC; Hague CJ; Khalil N; Leipsic J; Mayo J; Muller NL; Murphy D; Wright JL; Ryerson CJ
Ann Am Thorac Soc; 2019 Apr; 16(4):455-462. PubMed ID: 30608873
[TBL] [Abstract][Full Text] [Related]
8. Treatable traits: a comprehensive precision medicine approach in interstitial lung disease.
Khor YH; Cottin V; Holland AE; Inoue Y; McDonald VM; Oldham J; Renzoni EA; Russell AM; Strek ME; Ryerson CJ
Eur Respir J; 2023 Jul; 62(1):. PubMed ID: 37263752
[TBL] [Abstract][Full Text] [Related]
9. Unclassifiable interstitial lung disease: A review.
Skolnik K; Ryerson CJ
Respirology; 2016 Jan; 21(1):51-6. PubMed ID: 26059704
[TBL] [Abstract][Full Text] [Related]
10. Virtual communication is commonly used in Finnish interstitial lung disease multidisciplinary meetings.
Salonen J; Nurmi H; Hodgson U; Hasala H; Kilpeläinen M; Hollmen M; Purokivi M; Kaarteenaho R
Eur Clin Respir J; 2023; 10(1):2190210. PubMed ID: 36950471
[TBL] [Abstract][Full Text] [Related]
11. Management of interstitial lung disease associated with connective tissue disease.
Mathai SC; Danoff SK
BMJ; 2016 Feb; 352():h6819. PubMed ID: 26912511
[TBL] [Abstract][Full Text] [Related]
12. Interstitial Lung Disease in Patients With Systemic Sclerosis: Toward Personalized-Medicine-Based Prediction and Drug Screening Models of Systemic Sclerosis-Related Interstitial Lung Disease (SSc-ILD).
Khedoe P; Marges E; Hiemstra P; Ninaber M; Geelhoed M
Front Immunol; 2020; 11():1990. PubMed ID: 33013852
[TBL] [Abstract][Full Text] [Related]
13. Systemic Sclerosis Associated Interstitial Lung Disease: A Comprehensive Overview.
Mackintosh JA; Stainer A; Barnett JL; Renzoni EA
Semin Respir Crit Care Med; 2019 Apr; 40(2):208-226. PubMed ID: 31137061
[TBL] [Abstract][Full Text] [Related]
14. Management of connective tissue disease-associated interstitial lung disease.
Chartrand S; Fischer A
Rheum Dis Clin North Am; 2015 May; 41(2):279-94. PubMed ID: 25836643
[TBL] [Abstract][Full Text] [Related]
15. Advancing Symptom Alleviation with Palliative Treatment (ADAPT) trial to improve quality of life: a study protocol for a randomized clinical trial.
Graney BA; Au DH; Barón AE; Cheng A; Combs SA; Glorioso TJ; Paden G; Parsons EC; Rabin BA; Ritzwoller DP; Stonecipher JJ; Turvey C; Welsh CH; Bekelman DB
Trials; 2019 Jun; 20(1):355. PubMed ID: 31196156
[TBL] [Abstract][Full Text] [Related]
16. Clinical networks for ILD: casting light on diffuse lung shadows.
Harrison NK; Johnson N; Wilsher M
Thorax; 2010 Jun; 65(6):466-8. PubMed ID: 20522837
[No Abstract] [Full Text] [Related]
17. Improving Accessibility to Patients with Interstitial Lung Disease (ILD): Barriers to Early Diagnosis and Timely Treatment in Latin America.
Figueiredo RG; Duarte NFV; Campos DCB; de Jesus Diaz Verduzco M; Márquez ÁA; de Araujo GTB; Rubin AS
Int J Environ Res Public Health; 2024 May; 21(5):. PubMed ID: 38791861
[TBL] [Abstract][Full Text] [Related]
18. Practical Considerations for the Diagnosis and Treatment of Fibrotic Interstitial Lung Disease During the Coronavirus Disease 2019 Pandemic.
Wong AW; Fidler L; Marcoux V; Johannson KA; Assayag D; Fisher JH; Hambly N; Kolb M; Morisset J; Shapera S; Ryerson CJ
Chest; 2020 Sep; 158(3):1069-1078. PubMed ID: 32333929
[TBL] [Abstract][Full Text] [Related]
19. Assessment and management of connective tissue disease-associated interstitial lung disease.
Fischer A; Chartrand S
Sarcoidosis Vasc Diffuse Lung Dis; 2015 Jun; 32(1):2-21. PubMed ID: 26237351
[TBL] [Abstract][Full Text] [Related]
20. Interstitial lung diseases: an observational study in patients admitted in "Marius Nasta" Institute of Pulmonology Bucharest, Romania, in 2011.
Strâmbu I; Belaconi I; Stoicescu I; Ioniţă D; Cojocaru F; Niţă C; Dospinoiu D; Bumbăcea R
Pneumologia; 2013; 62(4):206-11. PubMed ID: 24734353
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
